Summary
Musculoskeletal diseases are the most prevalent conditions affecting the elderly today and cause significant suffering and disability in this population. The diagnosis of musculoskeletal disorders in older persons requires knowledge of the diseases which affect this age group, familiarity with the signs and symptoms, and a working knowledge of laboratory and radiographic abnormalities. Treatment of these disorders is based upon the principles of pain relief and maintenance of function. A multifaceted approach includes physical therapy, patient education, psychological support and the use of medications. Simple analgesics like paracetamol (acetaminophen) are gaining increased importance in the treatment of symptomatic disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most utilised pharmacological treatment and are effective in relieving pain and improving function in most patients. However, elderly persons are at increased risk for NSAID-induced toxicity, and drug choices should be made with this in mind. New data are becoming available as to the relative toxicity of the different NSAIDs, and this should help in choosing between these medications. Disease-modifying drug therapy is the most difficult to administer in elderly subjects. Potential toxicity must be weighed against realistic benefit in older persons prior to and during remittive therapy. With appropriate precautions, these agents can prove invaluable in the treatment of older persons with serious musculoskeletal disease.
Similar content being viewed by others
References
Alexander GM, Dieppe PA, Doherty M, Scott DG. Pyrophosphate arthropathy: a study of metabolic associations and laboratory parameters. Annals of Rheumatic Disease 41: 377–381, 1982
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. New England Journal of Medicine 327: 749–754, 1992
Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism 28: 686–692, 1985
Bianchi PG, Caruso I, Petrillo M, Montrone F, Ardizzone S. A double blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients. Journal of Internal Medicine 229: 5–8, 1991
Blackshear JL, Napier JS, Davidman M, Stillman MT. Renal complications of nonsteroidal anti-inflammatory drugs: identification and monitoring of those at risk. Seminars in Arthritis and Rheumatism 14: 163, 1985
Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI, et al. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. New England Journal of Medicine 325: 87–91, 1991
Brooks PM, Day RO. Nonsteroidal antiinflammatory drug - differences and similarities. New England Journal of Medicine 324: 1716–1725, 1991
Calkins E. Arthritis in the elderly. Bulletin on the Rheumatic Diseases 40: 1–9, 1991
Chang T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia Rheumatica - A 10 year epidemiologic and clinical study. Annals of Internal Medicine 97: 672, 1982
Chard MD, Hazelman R, Hazelman BL, King RH, Reiss BB. Shoulder disorders in the elderly: a community survey. Arthritis and Rheumatism 34: 766–769, 1991
Ciabattoni G, Pugliese F, Cinotti GA, Patrono C. Renal effects of anti-inflammatory drugs. European Journal of Rheumatology and Inflammation 3: 210, 1980
Collee G, Kijkmans BAC, Vandenbroucke JP, Cats A. Iliac crest pain syndrome in low back pain. A double blind, randomized study of local injection therapy. Journal of Rheumatology 18: 1060–1076, 1991
Cooper C, Cawley M. Bacterial Arthritis in an English health district: a 10 year review. Annals of Rheumatic Disease 45: 458–463, 1986
Corman LC. Clinical spectrum and treatment of rheumatic syndromes in the elderly. Medical Clinics of North America 73: 1371–1381, 1989
Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. Journal of Clinical Investigation 29: 496–507, 1950
Doherty M, Dieppe P. Crystal deposition in the elderly. Clinics of Rheumatic Disease 12: 97–114, 1985
Ellerington MC, Stevenson JC. Prevention of osteoporosis. Current recommendations. Drugs & Aging 2: 508–517, 1992
Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Annals of Rheumatic Disease 42: 168–170, 1983
Epstein WV, Henke CJ, Yelin EH, Katz PP. Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis. Annals of Internal Medicine 114: 437–444, 1991
Ettinger WH. Approach to the diagnosis and management of musculoskeletal disease. Clinics of Geriatric Medicine 4: 269–278, 1988
Ettinger WH, Davis MA. Osteoarthritis. In Hazzard et al. (Eds) Principles of geriatric medicine and gerontology, 2nd edn, pp. 880–888, McGraw-Hill, New York, 1990
Felson DT, Naimark A, Anderson JJ. The prevalence of knee osteoarthritis in the elderly: the Framingham study. Arthritis and Rheumatism 30: 914–918, 1987
Ferrell BA. Pain management in elderly people. Journal of the American Geriatrics Society 39: 64–73, 1991
Fiatarone MA, Mark EC, Ryan AD, Meredith CN, Lipsitz LA, et al. High intensity strength straining in nonagenarians. Journal of the American Medical Association 263: 3029–3035, 1990
Fisher NM, Pendergast DR, Gresham GE, Calkins E. Muscle rehabilitation: its effect on muscular and functional performance of patients with knee osteoarthritis. Archives of Physical Medicine and Rehabilitation 72: 367–374, 1991
Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism 34: 1353–1360, 1991
Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Annals of Internal Medicine 115: 787–796, 1991
Garella S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine 63: 165–178, 1984
Gerber LH. Exercise and arthritis. Bulletin on the Rheumatic Diseases 39: 1–8, 1990
Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine 114: 257–264, 1991
Hench PK, Mitler MM. Fibromyalgia: review of a common rheumatologic syndrome. Postgraduate Medicine 80: 47–56, 1986
Hodgkinson HM. Alterations of laboratory findings. In Andres et al. (Eds) Principles of geriatric medicine and gerontology, 2nd edn, pp. 387–396, McGraw-Hill, New York, 1985
Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis: a randomized, double-blind study. Annals of Internal Medicine 114: 999–1004, 1991
Keefe FJ, Caldwell DS, Queen DT, Gil KM, Martinez S, et al. Pain coping strategies in osteoarthritis patients. Journal of Consulting and Clinical Psychology 55: 208–212, 1987
Lawrence JS, Bremner JM, Bier F. Osteo-arthrosis: prevalence in the population and relationship between symptoms arid x-ray changes. Annals of Rheumatic Disease 25: 1–24, 1966
Liang MH, Culler KE, Larson MG, Thompson MS, Schwartz JA, et al. Cost-effectiveness of total joint replacement in osteoarthritis. Arthritis and Rheumatism 29: 937–943, 1986
Maldague B, Malghem J. Dynamic radiologic patterns of Paget’s disease of bone. Clinical Orthopedics 217: 126, 1987
McCarthy DJ. Synovial fluid. In McCarthy (Ed.) Arthritis and allied conditions, 10th edn, pp. 54–75, Lea & Febiger, Philadelphia, 1985
Medical Letter. Abramowicz (Ed.) Vol. 33, pp. 65–70, New Rochelle, New York, 1991
Nesher G, Moore TL, Zuckner J. Rheumatoid arthritis in the elderly. Journal of the American Geriatrics Society 38: 1339–1352, 1990
Petri M, Dobrow R, Neiman R, Whiting QO, Seaman WE, et al. Randomized, double-blind placebo-controlled study of the treatment of the painful shoulder. Arthritis and Rheumatism 30: 1040–1045, 1987
Riggs BL, Melton LJ. Involutional osteoporosis. New England Journal of Medicine 314: 1676–1682, 1986
Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. New England Journal of Medicine 327: 620–629, 1992
Roberts J, Burch TA. Prevalence of osteoarthritis in adults by age, sex, race, and geographic area: United States, 1960-1962. Vital Health and Statistics, series 11, PHS pub. no. 1000. Washington, DC, National Center for Health Statistics, 1966
Roth SH. Pharmacologic approaches to musculoskeletal disorders. Clinics in Geriatric Medicine 4: 441–461, 1988
Singer FR. Paget’s disease of bone. In Martin & Raisz (Eds) Clinical endocrinology of calcium metabolism, p. 369, Dekker, New York, 1987
Semble EL, Loeser RF, Wise CM. Therapeutic exercise for rheumatoid arthritis and osteoarthritis. Seminars in Arthritis and Rheumatism 20: 32–39, 1990
Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of Internal Medicine 114: 307–319, 1991
Stillman MT, Napier J, Blackshear JL. Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney. Medical Clinics of North America 68: 371–385, 1984
Weinberger M, Tierney WM, Boother P, Katz, BP. The impact of increased contact on psychosocial outcomes in patients with osteoarthritis: a randomized controlled trial. Journal of Rheumatology 18: 849–854, 1991
Weissmann J. The actions of NSAIDs. Hospital Practice 8: 60–76, 1991
Wolfe F, Cathey MA. The effect of age on methotrexate efficacy and toxicity. Journal of Rheumatology 18: 973–977, 1991
World Health Organization. The international classification of impairments, disabilities, and handicaps. World Health Organization, Geneva, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Afable, R.F., Ettinger, W.H. Musculoskeletal Disease in the Aged. Drugs & Aging 3, 49–59 (1993). https://doi.org/10.2165/00002512-199303010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199303010-00005